Connective tissue plays a crucial role in maintaining normal body structure and flexibility. In dogs affected by Musladin–Lueke Syndrome, a mutation disrupts the function of a gene involved in connective tissue development, leading to abnormal collagen organization. Collagen is a key structural protein responsible for strength and elasticity in skin, tendons, ligaments, and joints. When this protein is improperly formed, it results in a range of physical abnormalities that can affect mobility and appearance.
Clinical signs of MLS are typically noticeable early in life, often within puppyhood. Affected dogs may exhibit unusually tight or thick skin, reduced skin elasticity, and a distinctive “stiff” appearance. Joint abnormalities are also common, including reduced joint flexibility, limited range of motion, and a stiff-legged gait. The toes may appear unusually upright or “ballerina-like,” and movement can be restricted due to tight connective tissues. Despite these structural differences, many dogs with MLS remain active and alert, although their movement may be mechanically restricted.
Additional features may include short, upright ears, a broad skull appearance, and a compact, rigid posture. In some cases, dogs may experience delayed growth or abnormal limb development. Unlike many other genetic disorders, MLS primarily affects structural tissues rather than internal organ systems, and affected dogs are not typically associated with progressive neurological or life-threatening systemic disease.
The MLS DNA Health Test is designed to detect the specific genetic mutation responsible for Musladin–Lueke Syndrome. Testing is simple, safe, and non-invasive, typically requiring a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine the dog's genetic status. Because DNA does not change throughout a dog’s life, testing can be performed at any age, including in puppies before physical traits are fully developed.
Results are generally reported in three categories:
- Clear (Normal): The dog does not carry the MLS mutation and will not pass it to offspring.
- Carrier: The dog carries one copy of the mutation and may not show obvious clinical signs but can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and is expected to show physical characteristics associated with Musladin–Lueke Syndrome.
Genetic testing for MLS is highly valuable for breeders, veterinarians, and dog owners. Breeders can use test results to make informed breeding decisions that help eliminate the mutation from breeding populations while maintaining healthy genetic diversity. Avoiding carrier-to-carrier matings significantly reduces the risk of producing affected puppies.
For dog owners, understanding a dog’s genetic status helps explain physical traits and allows for appropriate lifestyle adjustments. Dogs with MLS may benefit from controlled exercise, careful joint monitoring, and preventive veterinary care to maintain comfort and mobility throughout life. While there is no cure for MLS, affected dogs can often live full lives with proper management.
The Musladin–Lueke Syndrome (MLS) Health Test is a reliable genetic screening tool that supports responsible breeding practices, improves awareness of connective tissue health, and helps reduce the impact of this inherited structural disorder in future generations.
